SLNH:NASDAQSoluna Holdings, Inc. Analysis
Data as of 2026-06-14 - not real-time
$1.48
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Soluna Holdings trades at $1.48, well below its 20‑day SMA of $1.66 and the 200‑day SMA of $1.57, indicating short‑term price weakness despite a neutral longer‑term trend. The RSI sits at 47, suggesting the stock is neither oversold nor overbought, while the MACD histogram is negative, reinforcing a bearish momentum signal. Volatility is extreme at 136% (30‑day) and beta exceeds 4.6, exposing the equity to outsized market swings. Fundamentally, the company reports a negative PE of –3.2, operating losses (‑1.77% operating margin) and a steep max drawdown of ‑86%, yet it holds $68.6 M in cash against $27.9 M of debt, providing a modest liquidity cushion. The upside/downside potential of 238% (target $5 vs current $1.48) and an “Extreme Greed” sentiment index of 89.86 hint at speculative enthusiasm. Recent material news highlights the acquisition of full ownership of Project Dorothy 1B and the addition of a 150 MW wind farm, positioning the firm for renewable‑powered AI compute capacity. This strategic shift could unlock new revenue streams but remains dependent on volatile cryptocurrency markets and regulatory developments. Overall, the stock presents a high‑risk, high‑potential profile where technical weakness clashes with a long‑run growth narrative driven by green data‑center expansion.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price below 20‑day SMA and bearish MACD
- Decreasing volume trend
- High short‑term volatility and beta
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Acquisition of Project Dorothy 1B and renewable energy assets
- Potential AI‑compute demand growth
- Improving cash‑to‑debt ratio
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Target price upside of ~237% to $5
- Strategic shift toward green data‑center and AI services
- Long‑run industry tailwinds in renewable‑powered computing
Key Metrics & Analysis
Financial Health
Revenue Growth58.30%
Profit Margin-190.87%
P/E Ratio-3.2
ROE-95.56%
ROA-19.22%
Debt/Equity24.48
P/B Ratio3.4
Op. Cash Flow$-15344000
Free Cash Flow$-34616500
Industry P/E16.8
Technical Analysis
TrendNeutral
RSI47.0
Support$1.25
Resistance$2.36
MA 20$1.66
MA 50$1.44
MA 200$1.57
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Target Price$5.00
Upside/Downside237.84%
GradeUndervalued
TypeBlend
Risk Assessment
Beta4.65
Volatility136.46%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.